Inventor · Dallas, TX, US

Eric Olson

54Patents
10h-index
41Co-inventors
78Inventor score

Filing activity: Nov 14, 1995 → Aug 2, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6706686B2 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy Human Necessities 45 Expired
US6946441B2 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy Human Necessities 32 Expired
US6201165A Transgenic animal models for cardiac hypertrophy and methods of use thereof Physics 19 Expired
US7981935B2 Stem cell differentiating agents and uses therefor Chemistry; Metallurgy 19 Active
US8318951B2 Stem cell differentiating agents and uses therefor Chemistry; Metallurgy 18 Active
US6632628B1 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression Physics 17 Expired
US6015711A Smooth muscle 22.alpha. promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells Chemistry; Metallurgy 17 Expired
US5837534A Smooth muscle 22.alpha. promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells Chemistry; Metallurgy 13 Expired
US6372957B1 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use Chemistry; Metallurgy 12 Expired
US8304397B2 Identification of a micro-RNA that activates expression of β-myosin heavy chain Chemistry; Metallurgy 10 Active
US8481507B2 Micro-RNAs that control myosin expression and myofiber identity Chemistry; Metallurgy 9 Active
US8440636B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 8 Active
US8940713B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 6 Active
US8940712B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 6 Active
US8940711B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 6 Active
US9523079B2 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes Chemistry; Metallurgy 5 Active
US8629119B2 Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders Chemistry; Metallurgy 5 Active
US6657104B1 Transgenic mouse model for cardiac hypertrophy and methods of use thereof Physics 4 Expired
US9017661B2 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes Chemistry; Metallurgy 4 Active
US7863414B2 Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain Physics 4 Active
US9428749B2 Control of whole body energy homeostasis by microRNA regulation Chemistry; Metallurgy 2 Active
US8202848B2 Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration Physics 2 Active
US9719087B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 2 Active
US8513209B2 Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair Chemistry; Metallurgy 2 Active
US9719088B2 Micro-RNA family that modulates fibrosis and uses thereof Emerging Cross-Sectional Technologies 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.